4DMedical posts FY26 revenue growth as commercial deployment ramps up
4DMedical reports 21% FY26 revenue growth as CT:VQ gains commercial adoption, global regulatory approvals and major healthcare partnerships.
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
| Tag | Subject | ||||||
|---|---|---|---|---|---|---|---|
| VLT | Ann: Quarterly Update and Appendix 4C 31 March 2018 | 22/04/18 | 9 | 1.3K | |||
|
|||||||
| VLT | Ann: Corporate Governance Statement 19 September 2017 | 13/04/18 | 0 | 130 | |||
|
|||||||
| VLT | Ann: New Vault Platform Successfully Launched & Generating Sales | 08/03/18 | 2 | 858 | |||
|
|||||||
| VLT | Linkedin commentary by Verdon Kelliher, VP of Vault | 01/03/18 | 0 | 321 | |||
|
|||||||
| VLT | Ann: Investor Presentation | 28/02/18 | 0 | 220 | |||
|
|||||||
| VLT | Ann: Half Year Results Review - 31 December 2017 | 28/02/18 | 0 | 172 | |||
|
|||||||
| VLT | Ann: Appendix 4D and Half Year Accounts | 28/02/18 | 0 | 137 | |||
|
|||||||
| VLT | Ann: Cornerstone Signing in Food Services and Healthcare Vertical | 27/02/18 | 12 | 2.5K | |||
|
|||||||
See All Discussions
ASX News